Trial · NCT01751906
Outcomes52
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 52
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Cardiac Death/TV-MI/ID-TLR (TLF) | 1 year | Intent-To-Treat Population set (ITT). The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Powered Secondary Endpoint: Angina | 1 year | The analysis will exclude angina following the index procedure through discharge, not to exceed a period of 7 days. ITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Powered Secondary Endpoint: All Revascularization | 1 year | ITT population. Analysis population excludes subjects who are truly lost-to-follow-up, defined as subjects who are terminated through 1 year without any DMR event (all death, all MI (regardless of MI definition), all revascularization, respectively). | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Powered Secondary Endpoint: Ischemia Driven Target Vessel Revascularization (ID-TVR) | 1 year | For ID-TVR, Fisher's exact test is used for superiority testing based on the ITT population. This analysis will include \~2000 subjects. ITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Acute Success- Device Success (Lesion Level Analysis) | On day 0 (the day of procedure) | Intent-To-Treat Population set (ITT). The number of participants analyzed includes subjects who had available follow up data at that time frame. | Percentage of lesions | NUMBER |
| SECONDARY | Acute Success: Procedural Success (Subject Level Analysis) | On day 0 (the day of procedure) | Intent-To-Treat Population set (ITT). The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Death (Cardiac, Vascular, Non-cardiovascular) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All Myocardial Infarction (MI) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All Target Lesion Revascularization (TLR) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All Target Vessel Revascularization (TVR) Excluding Target Lesion Revascularization (TLR) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With All Revascularization | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Death/All MI | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Cardiac Death/All MI | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Cardiac Death/TV-MI/ID-TLR (TLF) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Cardiac Death/All MI/ID-TLR (Major Adverse Cardiac Events-MACE) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Target Vessel Failure (TVF) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Death/All MI/All Revascularization (DMR) | 0 to 5 years | ITT set. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Acute Stent/Scaffold Thrombosis (Per ARC Definition) | ≤ 1 Day | Analyzed population excludes subjects who are truly lost-to-follow-up, defined as subjects who are terminated through a given time point without any Stent/Scaffold Thrombosis event. ITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Acute/Subacute Stent/Scaffold Thrombosis (Per ARC Definition) | 0 to 30 Days | Analyzed population excludes subjects who are truly lost-to-follow-up, defined as subjects who are terminated through a given time point without any Stent/Scaffold Thrombosis event. ITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Subacute Stent/Scaffold Thrombosis | >1 to 30 Days | Analyzed population excludes subjects who are truly lost-to-follow-up, defined as subjects who are terminated through a given time point without any Stent/Scaffold Thrombosis event. ITT population. The number of participants analyzed includes subjects who had available follow up data at that time frame. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01751906/outcomes